Saccomano Nicholas A 4
4 · OnKure Therapeutics, Inc. · Filed Jun 24, 2026
Research Summary
AI-generated summary of this filing
OnKure (OKUR) CEO Nicholas Saccomano Sells 86 Shares
What Happened
- Nicholas A. Saccomano, President & CEO and a director of OnKure Therapeutics (OKUR), had 86 shares disposed on June 22, 2026. The shares were sold at a weighted average price of $4.40 per share for total proceeds of about $378.
- The sale was an automatic "sell to cover" tied to the vesting of restricted stock units (RSUs), i.e., shares were sold to satisfy tax withholding obligations rather than an open-market investment decision.
Key Details
- Transaction date: 2026-06-22; filing date: 2026-06-24 (timely Form 4).
- Price: weighted average $4.40; individual trade prices ranged $4.27–$4.54 (multiple trades per filing footnote).
- Proceeds: approximately $378.
- Shares owned after transaction: not specified in the filing.
- Relevant footnotes:
- F1: Sale was automatic to cover tax withholding for RSU vesting.
- F2: Multiple trade prices; weighted average reported (full breakdown available on request).
- F3: These securities were RSUs (each RSU converts to one share upon vesting).
- F4: Filing notes the Reporting Person acquired 4,000 shares under the 2024 ESPP on May 20, 2026.
- Transaction type: Reported as a sale (S) to cover taxes — routine and administrative (code F-type activity).
Context
- This was a small, routine tax-withholding sale tied to RSU vesting, common when equity awards vest. Such transactions typically reflect administrative tax settlement rather than a directional bet on the company.
- For retail investors, purchases by insiders may be more informative about confidence than routine withholding sales; this filing does not indicate a substantive change in insider ownership policy.
Insider Transaction Report
Form 4
Saccomano Nicholas A
DirectorPresident and CEO
Transactions
- Sale
Class A Common Stock
[F1][F2][F3][F4]2026-06-22$4.40/sh−86$378→ 11,247 total
Footnotes (4)
- [F1]These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.27 to $4.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- [F4]Includes 4,000 shares acquired under the Issuer's 2024 Employee Stock Purchase Plan on May 20, 2026.
Signature
/s/ Rogan Nunn, by power of attorney|2026-06-24